Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8476 to 8490 of 8903 results

  1. COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community (NG165)

    This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.

    Withdrawn guideline

  2. COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD) (NG168)

    May 2022: This guideline has been withdrawn because current practice is to manage COVID-19 risk in line with risk of other respiratory infections. For people with COPD see our guideline on diagnosing and managing COPD in over 16s and for people with COVID-19 see our guideline on managing COVID-19.

    Withdrawn guideline

  3. COVID-19 rapid evidence summary: Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 (ES25)

    This evidence summary was produced at the start of the COVID-19 pandemic, when evidence was emerging. It has been withdrawn as the content is no longer relevant. See NICE's COVID-19 rapid guideline: managing COVID-19 for current guidance.

    Withdrawn advice

  4. COVID 19 rapid evidence summary: Anakinra for COVID-19 associated secondary haemophagocytic lymphohistiocytosis (ES26)

    This evidence summary was produced at the start of the COVID-19 pandemic, when evidence was emerging. It has been withdrawn as the content is no longer relevant. See NICE's COVID-19 rapid guideline: managing COVID-19 for current guidance.

    Withdrawn advice

  5. Diabetes: statins for secondary prevention of CVD (IND184)

    This guidance has been updated and replaced by NICE indicator 276.

    Withdrawn indicator

  6. Diabetes: statins for primary prevention of CVD (40 years and over) (IND183)

    This guidance has been updated and replaced by NICE indicator 275.

    Withdrawn indicator

  7. Diabetes: statins for primary prevention of CVD (T2DM and 10% risk) (IND182)

    This guidance has been updated and replaced by NICE indicator 274.

    Withdrawn indicator

  8. Atrial fibrillation: pulse rhythm assessment in people at risk (IND168)

    This indicator has been withdrawn following National Screening Committee recommendations and ongoing research.

    Withdrawn indicator

  9. Weight management: BMI calculation in preceding 5 years (IND167)

    This indicator has been withdrawn following discussions with the National Screening Committee.

    Withdrawn indicator

  10. Diabetes: T1DM and statins (IND166)

    This guidance has been updated and replaced by NICE indicator 277.

    Withdrawn indicator

  11. Cardiovascular disease prevention: statins for people newly diagnosed with hypertension or T2DM (IND162)

    This indicator has been updated and replaced by NICE indicator 287.

    Withdrawn indicator

  12. Weight management: BMI recording (long-term conditions) (IND151)

    This indicator has been updated and replaced by NICE indicator 320.

    Withdrawn indicator

  13. Diabetes: blood pressure (without moderate or severe frailty) (IND236)

    This indicator has been updated and replaced by NICE indicator 249.

    Withdrawn indicator

  14. Diabetes: annual psychological assessment (children) (IND57)

    This indicator has been updated and replaced by NICE indicator 313 and NICE indicator 314.

    Withdrawn indicator

  15. Diabetes: thyroid disease screening (children) (IND56)

    This indicator has been updated and replaced by NICE indicator 312.

    Withdrawn indicator